A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer
Clinical trial NCT00625430 · UNKNOWN
Trial details
- NCT number
- NCT00625430
- Sponsor
- Biotech Equity Partners Pty Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2012-12-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.